Prospective Randomized Controlled Trial for Prevention of Demineralization During Fixed Orthodontic Treatment
A Prospective Randomized Controlled Trial for Prevention of Enamel White Spot Lesions During Fixed Orthodontic Treatment
1 other identifier
interventional
99
1 country
1
Brief Summary
Treatment with fixed orthodontic appliances is often associated with pain, which poses great challenges in the efficient brushing of the teeth thus making the teeth more vulnerable to plaque formation. Treatment duration with fixed orthodontic appliances usually extends to 18 months or even longer in some cases. This prolonged vulnerability to plaque formation frequently leads to demineralization of teeth. There is also an increase in the number of plaque retentive sites due to the fixed appliances, leading to a rapid change in the bacterial composition of the dental plaque, particularly in the number of acidogenic bacteria. The resulting enamel decalcification is also known as white spot lesions (WSLs), which is an early sign of demineralization of enamel. Enamel WSLs (EWSLs) can be observed even as early as four weeks from the start of fixed orthodontic treatment. The occurrence of EWSLs adjacent to the orthodontic brackets ranges from 15 to 85%. The incidence of EWSLs development is higher in orthodontic patients as compared to the development of similar lesions in non-orthodontic patients. These EWSLs are not aesthetically pleasing and is certainly unacceptable when it develops during fixed orthodontic treatment that is usually performed in patients who often seek such treatment to improve their aesthetics. Additionally, even if the outcome of fixed orthodontic treatment is superior from well-aligned teeth, aesthetics can be greatly compromised with EWSLs. Therefore, the prevention of such lesions is an important concern for orthodontists. Though professionally applied topical fluoride varnish helps in remineralization of EWSLs, an adequate supply of calcium and phosphate ions is essential for remineralization. Therefore, EWSLs on maxillary teeth could be prevented and remineralized by the use of advanced novel topical fluoride varnish with added calcium and phosphate-based delivery system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Sep 2017
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2017
CompletedFirst Submitted
Initial submission to the registry
April 2, 2020
CompletedFirst Posted
Study publicly available on registry
April 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2021
CompletedApril 13, 2020
April 1, 2020
3.5 years
April 2, 2020
April 8, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Enamel White Spot Lesions index surface scores: Clinical evaluation (Subjective criteria)
Changes in EWSLs surface scores (using Gorelick's index, 1982) among three study groups (evaluated clinically). The Gorelick's index is graded as: 0 (no lesion), 1(moderate lesion), 2 (severe lesion) and 3 (cavitation) with lower score representing good outcome and higher score representing poor outcome.
24 months
Change in Enamel White Spot Lesions index surface scores: Photographic evaluation (Subjective criteria)
Changes in EWSLs surface scores (using Gorelick's index, 1982) among three study groups (evaluated photographically). The Gorelick's index is graded as: 0 (no lesion), 1(moderate lesion), 2 (severe lesion) and 3 (cavitation) with lower score representing good outcome and higher score representing poor outcome
24 months
Change in Laser fluoroscence values (Objective criteria)
Changes in mean DIAGNOdent scores among three study groups. The DIAGNOdent values (or laser fluorescence values) are visible on the device as digital readings from 0 to 99 with higher readings representing poor outcomes and lower readings representing good outcomes.
24 months
Secondary Outcomes (9)
Enamel White Spot Lesions index surface scores: Clinical evaluation (Subjective criteria)
6 months
Enamel White Spot Lesions index surface scores: Clinical evaluation (Subjective criteria)
12 months
Enamel White Spot Lesions index surface scores: Clinical evaluation (Subjective criteria)
18 months
Enamel White Spot Lesions index surface scores: Photographic evaluation (Subjective criteria)
6 months
Enamel White Spot Lesions index surface scores: Photographic evaluation (Subjective criteria)
12 months
- +4 more secondary outcomes
Study Arms (3)
Standard of care
OTHERControl will receive standard oral hygiene instructions (OHI every three months)
Standard of care + Fluoride varnish
ACTIVE COMPARATORIntervention 1 will receive standard OHI and application of topical fluoride varnish containing 5% NaF (Duraphat varnish®, Colgate-Palmolive (UK) Ltd., Guildford, Surrey, UK) every three months
Standard of care + Fluoride varnish with Tricalcium phosphate
EXPERIMENTALIntervention 2 will receive standard OHI and application of topical fluoride varnish containing 5% NaF + TCP (Clinpro white varnishTM, 3M ESPE, St Paul, MN, USA) every three months
Interventions
Duraphat varnish®, Colgate-Palmolive (UK) Ltd., Guildford, Surrey, UK
Clinpro white varnishTM, 3M ESPE, St Paul, MN, USA
Standard oral hygiene instructions every 3 months
Eligibility Criteria
You may qualify if:
- Subjects about to undergo multi-bracketed fixed orthodontic treatment will be invited to participate in this study.
You may not qualify if:
- History of fixed orthodontic treatment
- Presence of any developmental defects of enamel (DDE) on labial surfaces of teeth
- Presence of any dental anomalies or direct/indirect labial restorations on teeth
- History of long-term antibiotic usage
- Presence of untreated cavitated lesions
- Plaque level greater than 25%
- Patients requiring complicated orthognathic surgeries
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Hong Kong
Hong Kong, 999077, Hong Kong
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cynthia KY Yiu, MDS, PhD
The University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- A dental assistant will allocate the participants in the study to their respective groups. The examiner will not be informed about the study participant's group allocation information. The orthodontist performing the fixed orthodontic treatment will not know about the study participant's group allocation information as the topical fluoride varnish application in this study will be performed by another operator.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 2, 2020
First Posted
April 13, 2020
Study Start
September 15, 2017
Primary Completion
March 30, 2021
Study Completion
July 30, 2021
Last Updated
April 13, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share
Data Management Plan (DMP) has been submitted to the university repository and final data will be deposited to the university.